Search research articles
Contact Us
Filters
Showing results (101-110 of 150) with videos related to
Page
of 15
Sort By:
European Urology Oncology
|
October 31, 2025
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to Therapy
Karim Fizazi, Johann S de Bono, A Douglas Laird, et al.
Clinical Genitourinary Cancer
|
November 6, 2023
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2020
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, et al.
NPJ Precision Oncology
|
July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study
Sara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Minerva Urology and Nephrology
|
January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
Carlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
European Urology
|
March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2022
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
Maria V Dieci, Giuseppe Azzarello, Vittorina Zagonel, et al.
American Journal of Clinical Oncology
|
February 22, 2021
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)
Daniele Santini, Marco Stellato, Ugo De Giorgi, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 150) with videos related to
Sort By:
Page
of 15
European Urology Oncology
|
October 31, 2025
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to Therapy
Karim Fizazi, Johann S de Bono, A Douglas Laird, et al.
Clinical Genitourinary Cancer
|
November 6, 2023
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)
Alessandra Damassi, Malvina Cremante, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2020
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, et al.
NPJ Precision Oncology
|
July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study
Sara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Minerva Urology and Nephrology
|
January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
Carlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
European Urology
|
March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2022
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
Maria V Dieci, Giuseppe Azzarello, Vittorina Zagonel, et al.
American Journal of Clinical Oncology
|
February 22, 2021
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)
Daniele Santini, Marco Stellato, Ugo De Giorgi, et al.
Page
of 15